MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

Visomitin

CAS No. : 934826-68-3

MCE 國(guó)際站：Visomitin

產(chǎn)品活性：Visomitin (SKQ1) 是一種靶向線粒體的抗氧化劑，具有高的線粒體穿透能力和有效的抗氧化能力。

研究領(lǐng)域：Immunology/Inflammation  |  NF-κB  |  Metabolic Enzyme/Protease

作用靶點(diǎn)：Reactive Oxygen Species

In Vitro: Direct treatment of tumor infiltrating leukocytes with Visomitin (SkQ1) does not influence their cytotoxicity against Panc02 cells. While Visomitin does not affect viability of the cell lines, this drug at 500 nM concentration reduces heavily the proliferation of human PDAC cells.

In Vivo: Regarding systemic angiogenic factors, it is observed in serum of Pancreatic ductal adenocarcinoma (PDAC) bearing mice a decrease in KC in the group of continuous treatment with Visomitin (SkQ1). Treatment of the mice with Visomitin increases the level of VEGF molecules. The amount of MIP1a and prolactin is reduced in all Visomitin treatment groups or after the follow-up treatment, respectively. Also, an increase in the IL-6 and IL-13 amount is found in the Visomitin treated groups. TGF-b amount is decreased in the pretreatment setting. On the contrary, all schemes of the Visomitin treatment decrease the NKT cell percentage. The Visomitin treatment has prolonged the median survival of PDAC-bearing mice, but the difference does not reach the level of significance defined.

相關(guān)產(chǎn)品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  NF-κB Signaling Compound Library  |  Stem Cell Signaling Compound Library  |  FDA-Approved Drug Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Antioxidant Compound Library  |  Oxygen Sensing Compound Library  |  Ferroptosis Compound Library  |  Pyroptosis Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Mitochondria-Targeted Compound Library  |  D-α-Hydroxyglutaric acid disodium  |  8α-Tigloyloxyhirsutinolide 13-O-acetate  |  Anticancer agent 120  |  7-Hydroxy-4-methyl-2(1H)-quinolone  |  N-tert-Butyl-α-phenylnitrone-d₁₄  |  BDP 581/591 NHS ester  |  Cysteamine-d₄ hydrochloride  |  L-Ascorbic acid sodium salt  |  Manganese(salen) chloride  |  Hydroxyphenyl Fluorescein  |  Glucosamine sulfate  |  Maresin 1  |  Berberine  |  1,3-Dicaffeoylquinic acid  |  Ciprofloxacin  |  Jacareubin  |  Echinocystic acid  |  Lacto-N-fucopentaose I  |  Nisoldipine-d₆  |  Arg-Tyr  |  HKPerox-2  |  3-Indolepropionic acid  |  2-Methoxyestradiol-¹³C,d₃  |  Apoptosis inducer 13  |  Albendazole  |  QD394  |  AKBA  |  Cedrin  |  Deferoxamine  |  LZWL02003

熱門(mén)產(chǎn)品線：重組蛋白  |  化合物庫(kù)  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物  |  寡核苷酸  |  抗體  |  點(diǎn)擊化學(xué)

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry